Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2005; 11(21): 3234-3239
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3234
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3234
Table 1 Sequence and co-ordinate of primers and probes for RT-PCR analysis.
| Transcript | Oligonucleotide sequence (5’-3’) | Product size (bp) | Genome coordinate | |
| EBNA1 | 5’ primer | GATGAGCGTTTGGGAGAGCTGATTCTGCA | 273 | 67510-67539 |
| 3’ primer | TCCTCGTCCATGGTTATCAC | 108075-108056 | ||
| probe | AGACCTGGGAGCAGATTCAC | 67608-67627 | ||
| EBNA2 | 5’ primer | GCTGCTACGCATTAGAGACC | 339 | 47892-47911 |
| 3’ primer | TCCTGGTAGGGATTCGAGGG | 48616-48597 | ||
| probe | CAGCACTGGCGTGTGACGTGGTGTAAGTT | 48391-48420 | ||
| LMP1 | 5’ primer | TCCTCCTCTTGGCGCTACTG | 490 | 169383-169364 |
| 3’ primer | TCATCACTGTGTCGTTGTCC | 168740-168759 | ||
| probe | GAACAGCACAATTCCAAGGAACAATGCCTG | 169061-169090 | ||
| BZLF1 | 5’ primer | ATTGCACCTTGCCGCCACCTTTG | 608 | 103194-103180 |
| 3’ primer | CGGCATTTTCTGGAAGCCACCCGA | 102486-102463 | ||
| probe | CACTGCTGCTGCTGTTTGAACAGT | 102772-102795 | ||
| BARF1 | 5’ primer | GGCTGTCACCGCTTTCTTGG | 203 | 165560-165579 |
| 3’ primer | AGGTGTTGGCACTTCTGTGG | 165762-165743 | ||
| probe | CTGGTTTAAACTGGGCCCAGGAGAGGAGCA | 165644-165673 | ||
| BHRF1 | 5’ primer | GTCAAGGTTTCGTCTGTGTG | 211 | 53830-53849 |
| 3’ primer | TTCTCTTGCTGCTAGCTCCA | 54480-54461 | ||
| probe | ATGCACACGACTGTCCCGTATACAC | 54435-54411 |
Table 2 Comparison of clinicopathological data between EBVaGC and EBVnGC patients.
| EBVaGC (n = 13) | EBVnGC (n = 45) | P | |
| Age (yr) (mean±SD)1 | 59.76±10.17 | 57.31±14.05 | 0.5613 (t = 0.5844) |
| Sex | |||
| Male | 13 | 35 | 0.1466 (χ2 = 2.1070) |
| Female | 0 | 10 | |
| Tumor location | |||
| Cardia/body | 9 | 21 | 0.1516 (χ2 = 2.0566) |
| Antrum | 4 | 24 | |
| Histological subtype | |||
| Adenocarcinoma | 12 | 41 | 0.6704 (χ2 = 0.1811) |
| Signet ring carcinoma | 1 | 4 | |
| Tumor differentiation | |||
| Moderate | 1 | 7 | 0.7890 (χ2 = 0.0716) |
| Poor | 12 | 38 | |
| Lymph node metastasis | |||
| Present | 10 | 33 | 0.9999 (χ2 = 0.0098) |
| Absent | 3 | 12 | |
| Tumor stage2 | |||
| Early | 0 | 1 | 1.0000 |
| Advanced | 13 | 44 |
Table 3 Apoptotic index and ki-67 index in EBVaGC and EBVnGC (mean±SD).
Table 4 bcl-2 and p53 expression in EBVaGC and EBVnGC.
| n | bcl-2 | p53 expression | p53 overexpression | ||||
| + | - | + | - | + | - | ||
| EBVaGC | 13 | 7 | 6 | 11 | 2 | 2 | 11 |
| EBVnGC | 45 | 22 | 23 | 39 | 6 | 26 | 19 |
| χ2 | 0.0991 | 0.0716 | 7.2593 | ||||
| P value | 0.7529 | 0.7912 | 0.0085 | ||||
- Citation: Wang Y, Luo B, Yan LP, Huang BH, Zhao P. Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma. World J Gastroenterol 2005; 11(21): 3234-3239
- URL: https://www.wjgnet.com/1007-9327/full/v11/i21/3234.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i21.3234
